Daewoong Co.'s treasury shares approach 30%, the highest in South Korea's pharma sector, raising concerns among experts about governance risks and shareholder value dilution.
#YonhapInfomax #Daewoong #TreasuryShares #ShareholderValue #CorporateGovernance #PharmaceuticalSector #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=69408

Yuhan Corporation reports lower-than-anticipated Q1 operating profit of 8.6 billion won, signaling potential challenges in the pharmaceutical sector
#YonhapInfomax #YuhanCorporation #Q1Earnings #OperatingProfit #PharmaceuticalSector #FinancialPerformance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=62244

Hanmi Pharmaceutical reports Q1 operating profit of 59 billion won, meeting market expectations and signaling steady performance in pharmaceutical sector
#YonhapInfomax #HanmiPharmaceutical #Q1Earnings #OperatingProfit #PharmaceuticalSector #MarketExpectations #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60948

HanmiScience reports significant decline in Q1 operating profit, reflecting challenging market conditions in pharmaceutical sector
#YonhapInfomax #HanmiScience #Q1Earnings #OperatingProfit #YearOnYearDecline #PharmaceuticalSector #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=60469